2010
Improving Drug Design: Considerations for the Structural Modification Process
Nassar A. Improving Drug Design: Considerations for the Structural Modification Process. 2010, 163-216. DOI: 10.1002/9780470890387.ch4.Peer-Reviewed Original Research
2008
Minimizing the Potential for Drug Bioactivation of Drug Candidates to Success in Clinical Development
Nassar A. Minimizing the Potential for Drug Bioactivation of Drug Candidates to Success in Clinical Development. 2008, 283-306. DOI: 10.1002/9780470439265.ch12.Peer-Reviewed Original Research